BR9606821A - Processo de racemização para uso na fabricação de levobupivacaina e agentes anestésicos correlacionados de piperidina carboxanilida - Google Patents
Processo de racemização para uso na fabricação de levobupivacaina e agentes anestésicos correlacionados de piperidina carboxanilidaInfo
- Publication number
- BR9606821A BR9606821A BR9606821A BR9606821A BR9606821A BR 9606821 A BR9606821 A BR 9606821A BR 9606821 A BR9606821 A BR 9606821A BR 9606821 A BR9606821 A BR 9606821A BR 9606821 A BR9606821 A BR 9606821A
- Authority
- BR
- Brazil
- Prior art keywords
- levobupivacaine
- manufacture
- correlated
- piperidine
- anesthetic agents
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- LEBVLXFERQHONN-INIZCTEOSA-N levobupivacaine Chemical compound CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-INIZCTEOSA-N 0.000 title abstract 2
- 229960004288 levobupivacaine Drugs 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 230000002596 correlated effect Effects 0.000 title 1
- 239000003193 general anesthetic agent Substances 0.000 title 1
- UICIJOHWFFTRLI-UHFFFAOYSA-N n-phenylpiperidine-1-carboxamide Chemical compound C1CCCCN1C(=O)NC1=CC=CC=C1 UICIJOHWFFTRLI-UHFFFAOYSA-N 0.000 title 1
- 230000006340 racemization Effects 0.000 title 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 239000006184 cosolvent Substances 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 239000002609 medium Substances 0.000 abstract 1
- -1 piperidine-2-carboxanilide compound Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Rolling Contact Bearings (AREA)
- Optical Head (AREA)
- Beans For Foods Or Fodder (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9501071.6A GB9501071D0 (en) | 1995-01-18 | 1995-01-18 | Racemisation |
| PCT/GB1996/000067 WO1996022281A1 (en) | 1995-01-18 | 1996-01-12 | Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9606821A true BR9606821A (pt) | 1997-12-23 |
Family
ID=10768271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9606821A BR9606821A (pt) | 1995-01-18 | 1996-01-12 | Processo de racemização para uso na fabricação de levobupivacaina e agentes anestésicos correlacionados de piperidina carboxanilida |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0804417B1 (pt) |
| JP (1) | JP4015696B2 (pt) |
| KR (1) | KR100404390B1 (pt) |
| CN (1) | CN1172912C (pt) |
| AT (1) | ATE242214T1 (pt) |
| AU (1) | AU701221B2 (pt) |
| BR (1) | BR9606821A (pt) |
| CA (1) | CA2208522C (pt) |
| DE (1) | DE69628540T2 (pt) |
| DK (1) | DK0804417T3 (pt) |
| ES (1) | ES2201166T3 (pt) |
| FI (1) | FI117437B (pt) |
| GB (1) | GB9501071D0 (pt) |
| HU (1) | HU227426B1 (pt) |
| MX (1) | MX9705428A (pt) |
| NO (1) | NO308843B1 (pt) |
| PL (1) | PL184091B1 (pt) |
| PT (1) | PT804417E (pt) |
| WO (1) | WO1996022281A1 (pt) |
| ZA (1) | ZA96403B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0002246A (pt) * | 2000-04-06 | 2003-04-15 | Cristalia Prod Quimicos Farm | Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis |
| US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| CN101797221B (zh) | 2002-12-13 | 2013-06-12 | 杜雷科特公司 | 包含高粘度液体载体材料的口服递药系统 |
| HUE032040T2 (en) | 2004-09-17 | 2017-09-28 | Durect Corp | Saib-containing (sucrose acetate-isobutyrate) sustained-release local anesthetic composition |
| US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| US8337883B2 (en) | 2006-11-03 | 2012-12-25 | Durect Corporation | Transdermal delivery systems |
| AU2008335809A1 (en) | 2007-12-06 | 2009-06-18 | Durect Corporation | Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition |
| US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
| CN102093284B (zh) * | 2010-12-29 | 2013-05-08 | 宜昌人福药业有限责任公司 | 富集哌啶-2-甲酰苯胺类旋光化合物的方法 |
| WO2014144975A1 (en) | 2013-03-15 | 2014-09-18 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| CA3028450A1 (en) | 2016-07-06 | 2018-01-11 | Durect Corporation | Oral dosage form with drug composition, barrier layer and drug layer |
| CN106187864B (zh) * | 2016-07-11 | 2018-11-23 | 江苏天和制药有限公司 | 一种由盐酸布比卡因制备高纯度布比卡因碱的方法 |
| WO2021146215A1 (en) | 2020-01-13 | 2021-07-22 | Durect Corporation | Sustained release drug delivery systems with reduced impurities and related methods |
| JP2024503402A (ja) | 2021-01-12 | 2024-01-25 | デュレクト コーポレーション | 徐放性薬物送達システム及び関連の方法 |
| US20250236897A1 (en) * | 2022-02-16 | 2025-07-24 | Teva Pharmaceuticals International Gmbh | Processes for preparation of avacopan and intermediates thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2301498A1 (fr) * | 1975-02-20 | 1976-09-17 | Maggioni & C Spa | Methode pour la racemisation d'une lysine optiquement active |
-
1995
- 1995-01-18 GB GBGB9501071.6A patent/GB9501071D0/en active Pending
-
1996
- 1996-01-12 CN CNB961915242A patent/CN1172912C/zh not_active Expired - Lifetime
- 1996-01-12 PL PL96321378A patent/PL184091B1/pl unknown
- 1996-01-12 AU AU43948/96A patent/AU701221B2/en not_active Expired
- 1996-01-12 DE DE69628540T patent/DE69628540T2/de not_active Expired - Lifetime
- 1996-01-12 AT AT96900349T patent/ATE242214T1/de active
- 1996-01-12 HU HU9901418A patent/HU227426B1/hu unknown
- 1996-01-12 CA CA002208522A patent/CA2208522C/en not_active Expired - Lifetime
- 1996-01-12 KR KR1019970704822A patent/KR100404390B1/ko not_active Expired - Lifetime
- 1996-01-12 DK DK96900349T patent/DK0804417T3/da active
- 1996-01-12 WO PCT/GB1996/000067 patent/WO1996022281A1/en not_active Ceased
- 1996-01-12 ES ES96900349T patent/ES2201166T3/es not_active Expired - Lifetime
- 1996-01-12 PT PT96900349T patent/PT804417E/pt unknown
- 1996-01-12 EP EP96900349A patent/EP0804417B1/en not_active Expired - Lifetime
- 1996-01-12 BR BR9606821A patent/BR9606821A/pt unknown
- 1996-01-12 MX MX9705428A patent/MX9705428A/es unknown
- 1996-01-12 JP JP52210296A patent/JP4015696B2/ja not_active Expired - Lifetime
- 1996-01-18 ZA ZA96403A patent/ZA96403B/xx unknown
-
1997
- 1997-07-17 FI FI973040A patent/FI117437B/fi not_active IP Right Cessation
- 1997-07-17 NO NO973312A patent/NO308843B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI117437B (fi) | 2006-10-13 |
| PL321378A1 (en) | 1997-12-08 |
| JPH11501905A (ja) | 1999-02-16 |
| HU227426B1 (en) | 2011-05-30 |
| CN1168134A (zh) | 1997-12-17 |
| PT804417E (pt) | 2003-09-30 |
| FI973040L (fi) | 1997-07-17 |
| KR19980701432A (ko) | 1998-05-15 |
| KR100404390B1 (ko) | 2004-01-31 |
| EP0804417B1 (en) | 2003-06-04 |
| FI973040A0 (fi) | 1997-07-17 |
| JP4015696B2 (ja) | 2007-11-28 |
| CA2208522A1 (en) | 1996-07-25 |
| CN1172912C (zh) | 2004-10-27 |
| NO973312D0 (no) | 1997-07-17 |
| NO308843B1 (no) | 2000-11-06 |
| ES2201166T3 (es) | 2004-03-16 |
| DE69628540T2 (de) | 2004-01-08 |
| HUP9901418A2 (hu) | 1999-08-30 |
| NO973312L (no) | 1997-07-17 |
| EP0804417A1 (en) | 1997-11-05 |
| ZA96403B (en) | 1997-01-20 |
| DK0804417T3 (da) | 2003-10-06 |
| DE69628540D1 (de) | 2003-07-10 |
| CA2208522C (en) | 2007-03-13 |
| WO1996022281A1 (en) | 1996-07-25 |
| MX9705428A (es) | 1997-11-29 |
| GB9501071D0 (en) | 1995-03-08 |
| AU4394896A (en) | 1996-08-07 |
| ATE242214T1 (de) | 2003-06-15 |
| PL184091B1 (pl) | 2002-08-30 |
| HUP9901418A3 (en) | 2001-01-29 |
| AU701221B2 (en) | 1999-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9606821A (pt) | Processo de racemização para uso na fabricação de levobupivacaina e agentes anestésicos correlacionados de piperidina carboxanilida | |
| DE69629670D1 (de) | Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen | |
| FI20030162A7 (fi) | Uusia yhdisteitä | |
| MX9700082A (es) | Composicion que consiste de morfina, polipirrolidona y oxido de polialquileno. | |
| DE59708838D1 (de) | Spiegelselektion und spiegelevolution von nucleinsäuren | |
| ES2160640T3 (es) | Nuevos (r)-5-carbamoil-8-fluoro-3-amino disustituido en n,n-3,4-dihidro-2h-1-benzopiranos. | |
| HN1996000017A (es) | Isotiazolonas | |
| DE69401717D1 (de) | Verfahren zur Aktivierung von polyanionischen,fluoreszierenden Farbstoffen in schwach dielektrischen Medien mit quaternären Oniumverbindungen | |
| EA200300362A1 (ru) | Способ генерирования молекулярно-функциональной сети | |
| DE69942068D1 (de) | Erzeugen eines nichtlinearen modells und erzeugen tzung desselben | |
| ATE201203T1 (de) | Chirale methylphenyloxazolidinone | |
| BR9814112B1 (pt) | sistema, processo e aparelho para atualizar uma base de dados. | |
| DK0914605T3 (da) | Molekylemodel for VLA-4-inhibitorer | |
| DE50213507D1 (de) | Verfahren und mittel zur beeinflussung von interzellulärer kommunikation und interzellulärem organellentransport | |
| HUP0002709A1 (hu) | Eljárás 1-helyzetben szubsztituált 4-(4-fluor-fenil)-3-(hidroxi-metil)-tetrahidropiridinek redukciójára | |
| ES2138734T3 (es) | Procedimiento para la preparacion de derivados de 1-(3-trialquilsililfenil)-2,2,2-trifluormetil etanona. | |
| EA200000689A1 (ru) | Способ получения пароксетин гидрохлорида | |
| PT1007498E (pt) | Processo para o fabrico de 2-halogenoindano-1-onas | |
| DE60104822D1 (de) | Pseudopolymorph von (-)-cis-2-(2-chlorphenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-on hydrochlorid | |
| EA200200776A1 (ru) | Этанольный сольват (-)-цис-2-(2-хлорфенил)-5,7-дигидрокси-8[4r-(3s-гидрокси-1-метил)пиперидинил]-4h-1-бензопиран-4-она | |
| EA199800028A1 (ru) | Винилсульфоксиды и способы их синтеза | |
| DE59700961D1 (de) | Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethylpiperidin (TAD) über das Zwischenprodukt 2,2,6,6-Tetramethyl-4-[(2,2,6,6-tetramethyl-4-piperidyliden)amino]-piperidin | |
| MX9706395A (es) | Particulas de celulosa, metodo para producirlas, y su uso. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Transfer |
Free format text: DARWIN DISCOVERY LIMITED (GB) |
|
| EG | Technical examination (opinion): publication of technical examination (opinion) |